Silvan Tuerkcan

Stock Analyst at JMP Securities

(2.27)
# 2,631
Out of 4,905 analysts
174
Total ratings
41.67%
Success rate
-3.08%
Average return

Stocks Rated by Silvan Tuerkcan

Jasper Therapeutics
Jul 8, 2025
Maintains: Market Outperform
Price Target: $70$12
Current: $3.33
Upside: +260.36%
CRISPR Therapeutics AG
Jun 27, 2025
Reiterates: Market Outperform
Price Target: $86
Current: $65.13
Upside: +32.04%
Nuvation Bio
Jun 25, 2025
Reiterates: Market Outperform
Price Target: $6
Current: $2.30
Upside: +160.87%
Exelixis
Jun 23, 2025
Maintains: Market Outperform
Price Target: $47$50
Current: $44.47
Upside: +12.44%
Elevation Oncology
Jun 10, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $0.38
Upside: -
Solid Biosciences
Jun 6, 2025
Reiterates: Market Outperform
Price Target: $15
Current: $6.39
Upside: +134.74%
Taysha Gene Therapies
May 29, 2025
Maintains: Market Outperform
Price Target: $5$6
Current: $2.57
Upside: +133.46%
Prime Medicine
May 20, 2025
Maintains: Market Outperform
Price Target: $10$6
Current: $4.13
Upside: +45.28%
Benitec Biopharma
May 15, 2025
Reiterates: Market Outperform
Price Target: $20
Current: $11.04
Upside: +81.16%
Foghorn Therapeutics
May 15, 2025
Reiterates: Market Outperform
Price Target: $9
Current: $6.14
Upside: +46.58%
Downgrades: Market Perform
Price Target: $6
Current: $2.21
Upside: +171.49%
Reiterates: Market Outperform
Price Target: $18
Current: $3.79
Upside: +374.93%
Reiterates: Market Outperform
Price Target: $20
Current: $5.65
Upside: +254.30%
Reiterates: Market Outperform
Price Target: $17
Current: $1.35
Upside: +1,159.26%
Reiterates: Market Perform
Price Target: n/a
Current: $0.41
Upside: -
Initiates: Market Outperform
Price Target: $4
Current: $0.89
Upside: +349.44%
Reiterates: Market Outperform
Price Target: $21
Current: $3.50
Upside: +500.00%
Downgrades: Market Perform
Price Target: n/a
Current: $1.48
Upside: -
Reiterates: Market Outperform
Price Target: $6
Current: $1.82
Upside: +229.67%
Maintains: Buy
Price Target: $240$280
Current: $291.80
Upside: -4.04%
Maintains: Market Outperform
Price Target: $18$18
Current: $9.87
Upside: +82.37%
Downgrades: Market Perform
Price Target: n/a
Current: $12.06
Upside: -